Antibody drug conjugate: the “biological missile” for targeted cancer therapy

Zhiwen Fu; Shijun Li; Sifei Han; Shi Chen; Yu Zhang

doi:10.1038/s41392-022-00947-7

Keywords

ConjugateAntibody-drug conjugateMonoclonal antibodyAntibodyDrugLinkerImmunoconjugateImmunotoxinCancer researchCytotoxic T cellChemistryPharmacologyMedicineImmunologyBiochemistryComputer science

Affiliated Institutions

Related Publications

Ligand-targeted therapeutics in anticancer therapy

Theresa M. Allen

2002 Nature reviews. Cancer 1617 citations

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

John W. Park , Keelung Hong , Dmitri B. Kirpotin +9 more

Anti-HER2 immunoliposomes produced enhanced antitumor efficacy via targeted delivery.

2002 PubMed 648 citations

Monoclonal Antibody Therapy for Cancer

Margaret von Mehren , Gregory P. Adams , Louis M. Weiner

Monoclonal antibody therapy has emerged as an important therapeutic modality for cancer. Unconjugated antibodies show significant efficacy in the treatment of breast cancer, non...

2003 Annual Review of Medicine 188 citations

Mapping Tumor Epitope Space by Direct Selection of Single-Chain Fv Antibody Libraries on Prostate Cancer Cells

Bin Liu , Fraser Conrad , Matthew R. Cooperberg +2 more

Abstract The identification of tumor-specific cell surface antigens is a critical step toward the development of targeted therapeutics for cancer. The epitope space at the tumor...

2004 Cancer Research 95 citations

Improving the efficacy of antibody-based cancer therapies

Paul Carter

2001 Nature reviews. Cancer 815 citations

Publication Info

Year: 2022
Type: review
Volume: 7
Issue: 1
Pages: 93-93
Citations: 1272
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Antibody drug conjugate: the “biological missile” for targeted cancer therapy

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1272

OpenAlex

Cite This

APA Style

                            
                                
                                    Zhiwen Fu, 
                                
                                    Shijun Li, 
                                
                                    Sifei Han
                                
                                et al.
                            
                            (2022). 
                            Antibody drug conjugate: the “biological missile” for targeted cancer therapy. 
                            Signal Transduction and Targeted Therapy
                            , 7
                            (1)
                            , 93-93.
                            https://doi.org/10.1038/s41392-022-00947-7
                        

Identifiers

DOI: 10.1038/s41392-022-00947-7